While the FDA finalizes how to test drugs it treats like heroin, Mass. eyes psychedelic therapy
FDA finalized new guidance for testing MDMA and psilocybin in trials, days after Massachusetts advanced its own psychedelic therapy pilot.
Read the full articleYou might also wanna read
The future of US psychedelic medicine is carved out by the FDA
The US Food and Drug Administration (FDA) has issued its first comprehensive guidance on how psychedelic drugs should best be studied in cli
The future of US psychedelic medicine is carved out by the FDA
The US Food and Drug Administration (FDA) has issued its first comprehensive guidance on how psychedelic drugs should best be studied in cli
Final psychedelics guidance suggests FDA is 'receptive' to helping companies succeed
The agency’s finalized recommendations for clinical testing of psychedelic compounds for mental health could pave the way for companies like
The debate about whether the NHS should use magic mushrooms to treat depression
Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 - with surpris
Australia Refined its Psychedelic Therapy Framework — Here's What's Changed
Almost three years ago, Australia made history when the Therapeutic Goods Administration (TGA) approved access to MDMA for the treatment of
Editorial: Psychedelics pilot could provide proof of medicinal value
With little fanfare, the House of Representatives last week approved creating a five-year psychedelics pilot program that would allow for th
VA, HHS to increase psychedelic therapy research for PTSD, military-related mental health issues
The agreement could help accelerate research into the use of MDMA, magic mushrooms and other psychedelics to address PTSD and other mental c
Comments
Sign in to join the conversation.
No comments yet. Be the first.